Ledent C, Valverde O, Cossu G, Petitet F, Aubert J F, Beslot F, Böhme G A, Imperato A, Pedrazzini T, Roques B P, Vassart G, Fratta W, Parmentier M
IRIBHN, Université libre de Bruxelles, B-1070 Brussels, Belgium.
Science. 1999 Jan 15;283(5400):401-4. doi: 10.1126/science.283.5400.401.
The function of the central cannabinoid receptor (CB1) was investigated by invalidating its gene. Mutant mice did not respond to cannabinoid drugs, demonstrating the exclusive role of the CB1 receptor in mediating analgesia, reinforcement, hypothermia, hypolocomotion, and hypotension. The acute effects of opiates were unaffected, but the reinforcing properties of morphine and the severity of the withdrawal syndrome were strongly reduced. These observations suggest that the CB1 receptor is involved in the motivational properties of opiates and in the development of physical dependence and extend the concept of an interconnected role of CB1 and opiate receptors in the brain areas mediating addictive behavior.
通过使中枢大麻素受体(CB1)基因失活来研究其功能。突变小鼠对大麻素药物无反应,证明CB1受体在介导镇痛、强化、体温过低、运动减少和低血压方面具有独特作用。阿片类药物的急性作用未受影响,但吗啡的强化特性和戒断综合征的严重程度大幅降低。这些观察结果表明,CB1受体参与阿片类药物的动机特性和身体依赖性的发展,并扩展了CB1和阿片受体在介导成瘾行为的脑区中相互关联作用的概念。